Elie Azoulay | Medicine and Health Sciences | Hypothesis Achievement Award

Published on by Research Hypothesis

Prof. Elie Azoulay | Medicine and Health Sciences | Hypothesis Achievement Award 

Intensive care medicine department, at Saint Louis hospital, France.

Prof. Elie Azoulay is a distinguished French intensivist and the Director of the Critical Care Department at Hôpital Saint-Louis in Paris. He is renowned for his pioneering work in managing critically ill immunocompromised patients. As the founder and director of Nine-I, a multinational group focusing on immunocompromised patients, and co-director of the Famirea Study Group, he has significantly advanced research in intensive care medicine. His leadership extends to founding GRRR-OH, a French multicenter group dedicated to critically ill immunocompromised patients. Prof. Azoulay’s academic contributions are further highlighted by his role as Editor-in-Chief of Intensive Care Medicine from 2012 to 2018, during which the journal’s impact factor rose from 5 to 18. He has also served as President of the European Society of Intensive Care Medicine and is an advisory board member for The Lancet Respiratory Medicine.

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education

Prof. Azoulay’s academic journey began at Paris VI University (Sorbonne), where he earned his MD in 1991. He furthered his expertise with a Master’s degree in Respiratory Physiology from Paris XII University in 1995. In 2002, he completed his PhD in Respiratory Physiology at Paris VII University (Descartes). His commitment to advancing medical science led him to obtain Habilitation to Conduct and Lead Research from Paris VII University in 2003. Additionally, he holds a University Diploma in Critical Care Management of Immunocompromised Patients from Université Paris Cité, obtained in 2012. His educational background underscores his dedication to both clinical excellence and research innovation in intensive care medicine.

💼 Experience

Prof. Azoulay has an extensive career in intensive care medicine, beginning as a medical intern at Bichat-Claude Bernard Hospital in Paris. He has held significant positions, including serving as a professor of medicine at Paris VII University since 2004. His leadership roles encompass founding and directing several research groups, such as GRRR-OH and Nine-I, focusing on critically ill immunocompromised patients. He has been actively involved in various committees, including the Strategy Committee of the Hospital Group in Paris and the Medical Staffing Group. Prof. Azoulay’s editorial contributions are notable, having served as Editor-in-Chief of Intensive Care Medicine and as an associate editor for prominent journals like Critical Care Medicine and American Journal of Respiratory and Critical Care Medicine. His work has significantly influenced the field of intensive care medicine, particularly concerning immunocompromised patients.link.springer.com

🔬 Research Interests

Prof. Azoulay’s research primarily focuses on the management of critically ill immunocompromised patients, particularly those with hematological malignancies or undergoing immunosuppressive therapies. His work addresses acute respiratory failure, infections, and the psychosocial impact on patients and their families. He has led multicenter studies on the outcomes of intensive care in immunocompromised patients and the prevalence of ICU-related conflicts. His research also delves into the prevention of mental health disorders in ICU settings and the development of strategies to support family members of critically ill patients. Through his interdisciplinary approach, Prof. Azoulay aims to enhance patient care and outcomes in intensive care units.

🏆 Awards

Prof. Azoulay’s exceptional contributions to intensive care medicine have been recognized with several prestigious awards. In 2021, he received the International KJF Award, acknowledging his significant impact on critical care research. His editorial leadership has been instrumental in elevating the impact factor of Intensive Care Medicine. Additionally, his involvement in various international research initiatives has garnered him recognition from global medical communities. These accolades reflect his dedication to advancing the field of intensive care medicine and improving patient outcomes worldwide.rigshospitalet.dk

📚 Top Noted Publications

Prof. Azoulay has authored over 1,200 publications, contributing extensively to the field of intensive care medicine. Notable among his works is the 2019 study on acute respiratory failure in immunocompromised adults, published in The Lancet Respiratory Medicine, which has been cited over 1,000 times. His 2022 research in JAMA on post-traumatic stress symptoms in family members of ICU patients has also garnered significant attention. These publications reflect his commitment to addressing both clinical and psychosocial aspects of critical care. His work continues to influence practices and policies in intensive care units globally.

📌 1. Outcomes in Immunocompromised Patients with Acute Hypoxemic Respiratory Failure Treated by High-Flow Nasal Oxygen

Journal: Intensive Care Medicine
Date: April 2025
DOI: 10.1007/s00134-025-07890-5
Authors: Elie Azoulay, Mélanie Métais, Virginie Lemiale, Djamel Mokart, et al.
Summary:
This multicenter study evaluates the effectiveness and outcomes of high-flow nasal oxygen (HFNO) in immunocompromised patients with acute hypoxemic respiratory failure (AHRF). Key findings suggest that early initiation of HFNO is associated with improved survival, particularly in hematologic patients. It supports HFNO as a frontline noninvasive respiratory support strategy in this vulnerable population.

📌 2. Correction: HELLO – A Protocol for a Cluster RCT to Enhance ICU Team Cohesion

Journal: Intensive Care Medicine Experimental
Date: January 2025
DOI: 10.1186/s40635-024-00702-y
Authors: Elie Azoulay, Nancy Kentish Barnes, Sheila Nainan Myatra, et al.
Summary:
This correction addresses minor protocol amendments in the HELLO trial, aimed at improving interpersonal relationships and teamwork among ICU professionals. The original trial focuses on evaluating whether targeted interventions can reduce burnout and enhance job satisfaction, thus improving team-based care delivery.

📌 3. Lack of Up-to-Date Studies and Data Conversion May Lead to Biased Results: A Response to Wang et al.

Journal: Critical Care
Date: December 2024
DOI: 10.1186/s13054-024-05223-4
Authors: Ali Ait Hssain, Amir Vahedian-Azimi, Elie Azoulay, et al.
Summary:
A scholarly rebuttal to a prior publication, emphasizing the importance of timely and context-relevant data in intensive care research. The authors argue that reliance on outdated studies and improper data interpretation can introduce significant bias in clinical decision-making and policy formulation.

📌 4. Complement System Activation: Bridging Physiology, Pathophysiology, and Therapy

Journal: Intensive Care Medicine
Date: November 2024
DOI: 10.1007/s00134-024-07611-4
Authors: Elie Azoulay, Julien Zuber, Djillali Annane, et al.
Summary:
A comprehensive review of complement system activation in critically ill patients, exploring its dual role in host defense and inflammatory damage. The paper highlights novel therapeutic targets and the need for individualized modulation in conditions like sepsis and ARDS.

📌 5. Treatment of Invasive Pulmonary Aspergillosis and Candidiasis in ICU Patients

Journal: American Journal of Respiratory and Critical Care Medicine
Date: November 2024
DOI: 10.1164/rccm.202410-2045ST
Authors: Oleg Epelbaum, Elie Azoulay, et al.
Summary:
This ATS Clinical Practice Guideline outlines evidence-based recommendations for diagnosing and treating invasive fungal infections in ICU settings. It provides a framework for empirical and targeted antifungal therapy, addressing the rising concern of fungal superinfections in critical care.

Conclusion

Professor Elie Azoulay is an outstanding candidate for the Research for Hypothesis Achievement Award. His pioneering work in the intensive care management of immunocompromised patients, groundbreaking contributions to mental health in ICU survivors and their families, and leadership in multicenter, hypothesis-driven trials position him as a globally respected clinician-scientist. His profile aligns deeply with the intent of the award—translating complex hypotheses into high-impact, patient-centered outcomes.

Ali Esmaeilzadeh Pilehroud | Child and adolescent psychology | Best Researcher Award

Published on by Research Hypothesis

Dr. Ali Esmaeilzadeh Pilehroud | Child and adolescent psychology | Best Researcher Award

Teacher and university professor at Allameh Tabataba’i University, Iran.

Dr. Ali Esmaeilzadeh Pilehroud is a dedicated scholar and practitioner in the fields of psychology and neuroscience, with a deep commitment to child mental health and cognitive development. Based at Allameh Tabataba’i University in Tehran, he combines academic research with field-based psychological support for school children. With numerous publications and books, his interdisciplinary approach bridges clinical therapy, cognitive neuroscience, and developmental psychology. He is a recognized member of Iran’s psychological community and continues to contribute to both national and international research efforts.

Professional Profile

Google Scholar

Education🎓

  • Ph.D. in Psychology, Allameh Tabataba’i University, Tehran, Iran

Experience💼

Dr. Ali Esmaeilzadeh Pilehroud serves as a teacher and university professor at Allameh Tabataba’i University, where he has actively contributed to both academic instruction and research in psychology and neuroscience. His work involves hands-on participation in therapy-related initiatives targeting elementary school children, integrating theoretical expertise with practical applications. He has collaborated on national research projects focused on neuroscience and child cognition, and serves as a mentor in academic and clinical psychology settings.

Research Interest🔬

  • Child psychology and early cognitive development

  • Neuroscience applications in therapeutic settings

  • Psychotherapy methods in educational environments

  • Immune response and HIV-related cognitive research

  • Behavioral analysis and intervention design for school-aged children

Top Noted Publications📚

  1. Title: Lack of Association Between Interleukin-10 Gene Promoter Polymorphisms with HIV Susceptibility and Progression to AIDS
    Authors: A. Ramezani, E. Kalantar, A. Aghakhani, M. Banifazl, M. Foroughi, A. Esmaeilzadeh, et al.
    Journal: Iranian Journal of Pathology
    Volume: 10(2), Pages: 141
    Year: 2015
    Citations: 10
    Focus: Investigates genetic polymorphisms in the IL-10 promoter and their association with HIV progression, concluding no significant link.
    Link (Journal homepage)

  1. Title: Evaluation of Acquired HIV Drug Resistance Among People Living with HIV Who Have Taken Antiretroviral Therapy for 9–15 Months in 14 Triangular Clinics in Iran, 2015–2016
    Authors: M. Mohraz, K. Tayeri, H. Namdari Tabar, Z. Bayat Jozani, L. Sadeghi, A. Esmaeilzadeh, et al.
    Journal: Intervirology
    Volume: 61(6), Pages: 292–300
    Year: 2019
    Citations: 9
    Focus: Evaluates early HIV drug resistance patterns in Iranian clinics, informing ART strategy adjustments.
    DOI:10.1159/000499162

  1. Title: Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIV-Positive Patients Receiving First Line Treatment in Iran
    Authors: L. Sadeghi, S. Moallemi, R.A. Tabatabai, A. Esmaeilzadeh, S. Ahsani-Nasab, et al.
    Journal: Infectious Disorders – Drug Targets (Formerly Current Drug Targets – Infectious Disorders)
    Volume/Issue: Not clearly specified
    Year: 2018
    Citations: 3
    Focus: Compares immune recovery rates across two different ART regimens among newly treated HIV-positive individuals.
    Journal site

  1. Title: Enhanced Immune Responses Against HIV-1 with Adenovector (gag and tat) Prime/Protein Boost Regimen and GM-CSF Injection
    Authors: N.H. Rouzbahani, S. Bayanolhagh, M. Gholami, A. Esmaeilzadeh, Z.B. Jozani, et al.
    Journal: Iranian Journal of Allergy, Asthma and Immunology
    Pages: 403–412
    Year: 2016
    Citations: 2
    Focus: Examines a novel prime-boost vaccine strategy for HIV using GM-CSF to enhance immune response.
    Journal site

  1. Title: Comparing Theory of Mind and Executive Functions in Obsessive Compulsive Disorder, Schizophrenia, and Normal Individuals
    Authors: Nikjou Vakilabad, A. Esmaeilzadeh Pilehroud
    Journal: Disruption in Design
    Year: 2024
    Focus: Analyzes cognitive differences across clinical and healthy groups using theory of mind and executive function measures.
    Note: Citation data and volume not yet indexed (recent publication). Likely part of interdisciplinary psychology/neuroscience journal or conference proceedings.

Conclusion

Dr. Ali Esmaeilzadeh Pilehroud exemplifies the qualities of a forward-thinking, interdisciplinary scholar in the domain of child and adolescent psychology. His contributions to research, education, and clinical intervention demonstrate exceptional commitment to improving mental health outcomes for young populations. His integration of neuroscience and therapy within educational settings, along with involvement in HIV-related neurodevelopmental studies, marks him as a well-rounded and impactful researcher.

Yonghong Li | Public Health | Best Researcher Award

Published on by Research Hypothesis

Yonghong Li | Public Health | Best Researcher Award

Prof Yonghong Li, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, China

Prof. Yonghong Li is an internationally recognized expert in minimally invasive spinal surgery, with a distinguished career in clinical practice, academic leadership, and medical research. He holds MD and PhD degrees from Seoul National University School of Medicine and is a fellow of both the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. As President of Wooridul Spine Hospital and Head of Neurosurgery at Armed Forces Chungpyung Hospital, Prof. Li has been instrumental in advancing endoscopic spine techniques. He serves as Editor-in-Chief of JMISST-Video and holds editorial positions in journals like European Spine Journal and PLOS One. His pioneering research and educational contributions have shaped the global discourse on spine care. Recognized by Marquis Who’s Who with a Lifetime Achievement Award, Prof. Li exemplifies clinical excellence, research innovation, and leadership in the global medical community.

Publication Profile

orcid

Education

Prof. Yonghong Li earned both his MD and PhD from the prestigious Seoul National University School of Medicine, South Korea, laying a solid foundation in neurosurgical and spinal sciences. His academic journey has been marked by consistent pursuit of excellence in spinal health, endoscopic surgical techniques, and clinical innovation. He further distinguished himself by earning fellowships from the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons, reflecting his commitment to international best practices and high-level clinical expertise. This educational background has enabled him to contribute significantly to medical literature and innovation in spinal surgery. His scholarly training, coupled with cross-border accreditations, positions him as a leading authority in spine surgery and a mentor for aspiring neurosurgeons and clinical researchers worldwide.

Experience

Prof. Li’s expansive professional experience spans clinical, academic, and research leadership roles. He is currently the Head of the Department of Neurosurgery at the Armed Forces Chungpyung Hospital and serves as President of Wooridul Spine Hospital. He plays key roles in national and international medical societies, including Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager for the Korean Minimally Invasive Spine Surgery Society. He also sits on the Inter-Ministerial Evaluation Committee for National R&D Projects (IRIS). As Editor-in-Chief of JMISST-Video and editorial board member for European Spine Journal, PLOS One, and Biomed Research International, he actively shapes scientific discourse. With numerous textbook editorships and scholarly contributions, Prof. Li has trained generations of spine surgeons and remains a guiding force in the field of minimally invasive spinal surgery.

Awards and Honors

Prof. Yonghong Li has received numerous accolades in recognition of his groundbreaking contributions to neurosurgery and spinal health. Notably, he was honored with the 2020 Gachon University President’s Special Award for Research Excellence, celebrating his innovations in minimally invasive techniques. In 2018, he received the prestigious Albert Nelson Marquis Lifetime Achievement Award, awarded by MARQUIS Who’s Who, which also listed him in their global registry of top professionals. His remarkable service as a clinical leader and researcher continues to earn global recognition. These awards reflect not only his academic and clinical excellence but also his unwavering commitment to pushing the boundaries of spinal surgery. Prof. Li’s honors affirm his role as a pioneer in the integration of technological innovation with surgical precision, establishing new standards for excellence in the global medical community.

Research Focus

Prof. Li’s research primarily focuses on minimally invasive spine surgery, particularly endoscopic approaches to lumbar and cervical spine conditions. His studies delve into the development of advanced surgical techniques, the learning curves involved, and postoperative outcomes such as pain management and complication rates. He also explores applications of endoscopic surgery in cases of intradural tumors and vertebroplasty-induced stenosis. Beyond surgery, Prof. Li contributes to public health and epidemiology, addressing climate change adaptation behaviors among schoolchildren and evaluating health interventions during heatwaves in China. This multidisciplinary approach bridges clinical innovation and population health, reflecting his dedication to holistic and scalable healthcare improvements. Through textbooks, peer-reviewed articles, and editorial work, Prof. Li has fostered international collaboration and knowledge dissemination, ensuring continuous evolution in spine care. His research continues to impact not only surgical outcomes but also broader medical and environmental health strategies.

Publication Top Notes

Knowledge, Attitude, Risk Perception, and Health-Related Adaptive Behavior of Primary School Children towards Climate Change: A Cross-Sectional Study in China

Effectiveness Evaluation of a Primary School-Based Intervention against Heatwaves in China

Comparison of ARIMA and LSTM in Forecasting the Incidence of HFMD Combined and Uncombined with Exogenous Meteorological Variables in Ningbo, China